Loading...

SBS: Future Leadership Will Drive Healthcare Diagnostics Forward Amidst Margin Pressures

Published
09 Feb 25
Updated
03 Nov 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-38.4%
7D
-16.4%

Author's Valuation

€33.341.0% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on 03 Nov 25

Fair value Decreased 8.97%

Analysts have revised their price target for Stratec downward from €36.58 to €33.30, citing expectations of slower revenue growth and a slight decrease in profit margins. What's in the News Tanja Bücherl will join STRATEC SE's Board of Management as Chief Financial Officer effective November 1, 2025.

Shared on 23 Aug 25

Fair value Decreased 9.68%

Automation And Digitalization Will Transform Healthcare Diagnostics

Stratec’s consensus price target has been revised downward, primarily reflecting lowered forecasts for both revenue growth and net profit margin, resulting in a new fair value of €37.32. What's in the News Stratec increased its dividend to €0.60 per share for 2024 (previously €0.55), totaling €7.3 million to be distributed.

Shared on 01 May 25

Fair value Decreased 2.69%

Automation And Digitalization Will Transform Healthcare Diagnostics

Shared on 23 Apr 25

Efficiency Measures And Acquisitions Like Natech Will Boost Future Market Presence

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

Efficiency Measures And Acquisitions Like Natech Will Boost Future Market Presence

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

Efficiency Measures And Acquisitions Like Natech Will Boost Future Market Presence

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Efficiency Measures And Acquisitions Like Natech Will Boost Future Market Presence

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

Efficiency Measures And Acquisitions Like Natech Will Boost Future Market Presence

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

Efficiency Measures And Acquisitions Like Natech Will Boost Future Market Presence

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 12 Mar 25

Fair value Increased 2.77%

Efficiency Measures And Acquisitions Like Natech Will Boost Future Market Presence

AnalystConsensusTarget has increased revenue growth from 6.2% to 6.9%.